For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 2.51 million shares were traded. APLT stock price reached its highest trading level at $1.1 during the session, while it also had its lowest trading level at $1.02.
Ratios:
For a deeper understanding of Applied Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.94 and its Current Ratio is at 1.94. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.12.
On December 02, 2024, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $13 to $2.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on November 29, 2024, whereas the target price for the stock was revised from $12 to $4.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 04 ’25 when Perfetti Riccardo sold 10,366 shares for $0.44 per share. The transaction valued at 4,561 led to the insider holds 890,409 shares of the business.
Funtleyder Leslie D. sold 14,502 shares of APLT for $6,381 on Mar 04 ’25. The insider now owns 390,459 shares after completing the transaction at $0.44 per share. On Mar 04 ’25, another insider, Chinoporos Constantine, who serves as the insider of the company, sold 447 shares for $0.44 each. As a result, the insider received 197 and left with 271,436 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLT now has a Market Capitalization of 154092992 and an Enterprise Value of 126273976. For the stock, the TTM Price-to-Sale (P/S) ratio is 1284.08 while its Price-to-Book (P/B) ratio in mrq is 8.71. Its current Enterprise Value per Revenue stands at 1043.587 whereas that against EBITDA is -1.134.
Stock Price History:
The Beta on a monthly basis for APLT is 1.97, which has changed by -0.8695122 over the last 52 weeks, in comparison to a change of 0.16845357 over the same period for the S&P500. Over the past 52 weeks, APLT has reached a high of $10.62, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is 95.06%, while the 200-Day Moving Average is calculated to be 109.22%.
Shares Statistics:
For the past three months, APLT has traded an average of 4.44M shares per day and 23092010 over the past ten days. A total of 141.94M shares are outstanding, with a floating share count of 125.32M. Insiders hold about 12.98% of the company’s shares, while institutions hold 61.16% stake in the company. Shares short for APLT as of 1757894400 were 9129207 with a Short Ratio of 2.06, compared to 1755216000 on 8783564. Therefore, it implies a Short% of Shares Outstanding of 9129207 and a Short% of Float of 6.38.
Earnings Estimates
A comprehensive evaluation of Applied Therapeutics Inc (APLT) is underway, with the input of 3.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.09 and low estimates of -$0.18.
Analysts are recommending an EPS of between -$0.45 and -$0.66 for the fiscal current year, implying an average EPS of -$0.57. EPS for the following year is -$0.54, with 3.0 analysts recommending between -$0.32 and -$0.66.
